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Abstract
Posttranslational modifications allow cells and organisms to adapt to their 
environment without the need to synthesize new proteins. The ubiquitin system 
is one of the most versatile modification systems as it does not only allow a simple 
on–off modification but, by forming a chain of ubiquitin molecules, allows convey-
ing multiple signals. The structure of the chains is dependent on the linkage to the 
previous ubiquitin molecule as every lysine can serve as an acceptor point for this 
modification. Different chain types code for specific signals ranging from protein 
degradation to protein targeting different cellular compartments. Recently the code 
of ubiquitin signals has been further expanded as branching and mixing of differ-
ent chain types has been detected. As an additional layer of complexity, modifica-
tions of the ubiquitin chain by ubiquitin-like modifiers, like NEDD8, SUMO, or 
ISG15, have been found. Here we will discuss the different chain types and the 
technical challenges which are associated with analyzing ubiquitin topology-based 
signaling.
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1. The ubiquitin-conjugating system
Since its discovery in the 1980s, the ubiquitin signaling system has gained 
recognition as one of the most versatile, yet complicated, posttranslational signal-
ing systems. The central component of the system is the small protein ubiquitin 
(76 aa). Ubiquitin itself is always expressed as an immature precursor protein, 
either fused to a ribosomal protein or as a head-to-tail fusion of five or six ubiquitin 
moieties. The precursor protein is processed co-translationally and cleaved off the 
fusion protein right at the ribosome [1] liberating the mature ubiquitin protein. 
The modification of a target protein with ubiquitin as a PTM utilizes an enzymatic 
cascade. In the first step, an ubiquitin-activating enzyme (E1) is binding ubiquitin 
while hydrolyzing one molecule of ATP to AMP forming a thiol ester of ubiquitin’s 
C-terminus with a cysteine residue in its active center. The activated ubiquitin can 
then be transferred to an ubiquitin-conjugating enzyme (E2) which again forms 
a thiol ester with a cysteine in its active center. Depending on the cascade which 
is used, the final transfer is catalyzed by one of three classes of ubiquitin ligases, 
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really interesting new gene (RING), ring between ring (RBR), or homologous to E6 
C-terminus ligases (HECT ligases) (Figure 1). While RING-type ligases are associ-
ating with the E2 enzyme and bringing the target protein in close proximity to the 
E2/E3 complex, RBR and HECT-E3 are able to bind ubiquitin itself. The final trans-
fer of ubiquitin to the target is then catalyzed without the help of an E2 enzyme.
This modification leads to a single modification of the substrate protein with 
ubiquitin but can also be extended by multiple rounds of modification with ubiq-
uitin itself being the acceptor of the modification, leading to the formation of the 
ubiquitin chain. The structure of the chain is dependent on which linkage is used 
within the ubiquitin chain. The chains highly varies in shape from a very compact 
structure for a K48-linked chain [2–4] to a long stretched shape in the case of K63 
[5, 6] and linear ubiquitination [3]. Each of the different chain topologies is associ-
ated with different biological functions. Besides the signaling through different 
chain topologies, ubiquitin signaling can also occur through modifications by a 
single ubiquitin (monoubiquitin) or multiple monoubiquitinations.
Like for many other PTM systems, the ubiquitin signaling system has pos-
sibilities to erase the signal by either disassembling the polyubiquitin chain or by 
removing ubiquitin from its target. These enzymes are called ubiquitin hydrolases 
or ubiquitin de-conjugating enzymes (DUBs). Most DUBs belong to the enzymatic 
class of cysteine hydrolases, which carry a cysteine in their active center. Research 
on DUB specificity has shown that these enzymes possess a high linkage specificity 
indicating clear regulatory functions in the cell and are not acting as simple quality 
check enzymes [7].
2. Ubiquitin-like modifiers (Ubl)
Besides ubiquitin, there are a number of proteins which share significant simi-
larity to ubiquitin. They fall essentially into two groups: proteins with a ubiquitin-
like domain and small proteins with a similar size as ubiquitin. The small Ubls like 
ubiquitin, SUMO, NEDD8, Urm1, Apg8, Apg12, ISG15, Fat10, and Ufm1 are highly 
Figure 1. 
The ubiquitin-conjugating system. Ubiquitin (gray folded structure) is expressed as fusions either with 
ribosomal subunits or as ubiquitin multimers, which are cleaved co-translational. The mature ubiquitin 
(orange) is released and under the consumption of one ATP bound to the activating enzyme (E1). The activated 
ubiquitin is then passed on to the conjugating enzyme (E2), which finally catalyzes the transfer to a substrate 
protein involving an E3 ligase. The reaction can then be repeated and catalyzes the formation of a polyubiquitin 
chain. Depending on the lysine residue in ubiquitin used, the chain can have different structures, as indicated in 
yellow for a linear ubiquitin chain or in red for a K48-linked chain.
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conserved among eukaryotes. Many of these small proteins have been found to 
be covalently conjugated to a substrate protein, utilizing their own conjugation 
cascades, which usually consists of an activating enzyme and a conjugating enzyme 
(see Table 1).
2.1 NEDD8
Neuronal precursor cell-expressed developmentally downregulated protein 8 
(NEDD8) is structurally the closest relative to ubiquitin. Its E1 enzyme is split into 
two different parts which are forming the activation enzyme (NAE1/UBA3) [8]. 
The activated NEDD8 moiety is transferred to the NEDD8-conjugating enzyme E2s 
(UBC12/UBE2M or UBE2F) and substrate-specific NEDD8 E3 ligase [9]. Unlike 
the large group of ubiquitin E3 ligases, there are only about 10 different NEDD8 E3 
ligases [9], and most of them belong to the group of RING E3 ligases.
The best-characterized physiological neddylation substrates are the cullin 
proteins (Cul-1, Cul-2, Cul-3, Cul-4A, Cul-4B, and Cul-5) which form the back-
bone structure of cullin-RING ligases (CRLs). The conjugation of the cullin subunit 
modulates the activity of E3 ligase [10]. Deconjugation of the NEDD8 is catalyzed 
by the signalosome complex which removes NEDD8 from the cullin [11–14].
Recently, several other proteins have been identified, which are modified by 
NEDD8 including ubiquitin itself, p53, mouse double minute 2, and epidermal 
growth factor receptor (EGFR) [15–17].
2.2 SUMO
Small ubiquitin-related modifier (SUMO) is probably the best-studied Ubl pro-
tein. It is highly conserved among eukaryotes with one gene in lower eukaryotes like 
baker’s yeast (Smt3) [18] which developed into three homologs in humans, SUMO-
1, SUMO-2, and SUMO-3. SUMO-2 and SUMO-3 are closely related, while SUMO-1 
is more divergent. SUMO-1 does not form polymeric chains, while SUMO-2 and 
SUMO-3 mainly form K11-linked homotypic SUMO chains [19, 20]. SUMO-1 can 
be linked to the end of a poly-SUMO-2/SUMO-3 chain, effectively terminating 
chain growth [20]. Like NEDD8, SUMO is activated by a dimeric activating enzyme 
(SAE1/SAE2). The recognition of the target proteins is done by the conjugating 
enzyme Ubc9 which recognizes the main SUMOylation motif ΨKxE (Ψ = hydro-
phobic residue) [21–23]. Some reactions are further enhanced by the action of other 
E3 ligases, like RANBP2. These E3 ligases catalyze the transfer by recruiting the 
substrate or catalyzing the transfer of SUMO from Ubc9 [24, 25]. Similar to other 
Ubls, modification with SUMO can be reversed by specific proteases as summarized 
in Pichler [26].
Most SUMO-1 is conjugated to RANGAP1 near the nuclear pore. SUMO-2 is 
partially cytosolic, while SUMO-3 is mainly located in nuclear bodies. In unstressed 
cells, most SUMO-2 and SUMO-3 are not conjugated. Upon stress induction  
Ubl E1 E2
NEDD8 UBA3 (UBE1C), APPBP1 (NAE1) UBE2M
SUMO SAE1, SAE2 UBE2I
ISG15 UBA7 UbcH8
Table 1. 
Ubiquitin-like modifiers that have been found linked to ubiquitin chains and their enzymatic activation 
cascade.
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(e.g., folding stress) both SUMO-2 and SUMO-3 get conjugated to target proteins 
[27]. SUMO-1 conjugation has been proposed to regulate trafficking between 
nucleus and cytosol but also change protein–protein interaction [26, 28, 29]. SUMO 
modification plays an important role in a number of cellular processes like DNA 
replication, cell cycle regulation, nuclear trafficking, signal transduction, and pro-
tein degradation [30–32]. Recently, large-scale studies identified more than 1000 
SUMO targets and increased the number of cellular processes even further [33].
2.3 ISG15
Unlike other small ubiquitin-like modifiers interferon-stimulated gene prod-
uct 15 (ISG15) contains two ubiquitin-fold domains. It is massively induced by 
interferon treatment, ischemia, DNA damage, and aging as a monomer as well as a 
conjugated protein (reviewed in [34]. ISGylation requires a three-step enzymatic 
cascade involving an E1 activating enzyme (Ube1L), an E2 conjugating enzyme 
(UbcH8), and an E3 ligase (Herc5 or TRIM25/EFP) [35]. ISGylation is reversed by 
Ub-specific protease USP18 [36].
Several protein targets and cellular functions have been identified, which are 
regulated by ISGylation. These include the regulation of DNA damage response, 
autophagy, protein synthesis, the downregulation of the ubiquitin-proteasome 
system, and the regulation of HIFɑ in response to hypoxia [37–42].
A particular interest is the finding that modification of nascent proteins by 
ISGylation occurs after viral infection [43]. Virus infection induces host antiviral 
responses, including induction of type I interferons [44–47]. The transcription fac-
tor IRF3 recruits HERC5 and induces conjugation of ISG15 onto IRF3. This modi-
fication attenuates the interaction between Pin1 and IRF3, thus antagonizing IRF3 
ubiquitination and degradation. Consistently, host antiviral responses are boosted 
or crippled in the presence or absence of HERC5, respectively [48–50].
3. Ubiquitin chain topology
Ubiquitination occurs in proteins at one or multiple lysine residues. Ubiquitin 
itself, containing seven lysine residues, can be ubiquitinated at each one of these 
lysine residues, as well as at the N-terminal methionine [51, 52]. Proteins can be 
monoubiquitinated, where a single ubiquitin is conjugated to a lysine residue in 
the substrate; multi-monoubiquitinated, where a single ubiquitin is conjugated to 
multiple lysine residues in the substrate; or polyubiquitinated, where the ubiquitin 
conjugated to the substrate is ubiquitinated itself. Polyubiquitinated chains can be 
divided into homotypic chains and heterotypic chains, and like for linear chains, 
different chain topologies lead to different structures and functions in the cell 
[53–58]. To add to this complexity, ubiquitin chains themselves can also be modified 
by ubiquitin-like modifiers (Figure 2).
3.1 Homotypic chains
Homotypic chains are composed of several ubiquitins linked together through 
the same lysine or N-terminal methionine residues. This leads to a total of eight 
possible chain types. Each chain adopts a different conformation: K6, K11, and K48 
adopt “compact” conformations, while K27, K29, K33, K63, and M1 adopt “open” 
conformations, allowing recognition of these chains by different ubiquitin-binding 
partners implicated in several signaling pathways [53–59]. A short description of 
the functions of homotypic chains is given below.
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Studying K6 chains is challenging since this chain is among the less abundant 
ubiquitin chains [60, 61]. Although its function is still not very clear, K6 has been 
implicated in mitophagy regulation [62–64] and DNA damage response [65]. More 
recently Michel et al. showed that HECT E3 ligase HUWE1, previously implicated 
in cellular processes like DNA repair, stress response, cell death, differentiation, 
and mitophagy [66, 67], assembles K6 chains [68]. Mitophagy is the process by 
which cells maintain the energy metabolism by removing damaged mitochondria. 
During this process, PINK1 accumulates on the surface of the mitochondrial outer 
membrane and recruits cytosolic PARKIN, an E3 ubiquitin ligase [69]. PARKIN 
then ubiquitinates mitochondrial proteins by generating canonical (K48 and K63) 
and noncanonical chains (K6 and K11) eventually leading to mitophagy [63]. USP30 
is the only known DUB anchored to the mitochondria outer membrane which has 
been seen to act as a regulator of mitophagy. Despite having been seen to cleave K6, 
K11, K48, and K53 chains, USP30 prefers K6 chains [62, 64]. Under normal condi-
tions, USP30 prevents mitophagy of normal mitochondria by maintaining ubiquiti-
nation at low levels. Under stress conditions and mitochondrial damage, PARKIN is 
recruited, highly increasing ubiquitination levels and inducing mitophagy. PARKIN 
and PINK1 are both mutated in patients with Parkinson’s disease [70, 71].
Although not many roles are known for K11 chains, it has been shown that 
these chains are key players in cell cycle regulation and proteasome degradation. 
The anaphase-promoting complex/cyclosome (APC/C) is an E3 ubiquitin ligase 
and essential for cell cycle regulation. Along with Ube2C, APC/C targets key 
players in the cell cycle, like securin and cyclin B1, for proteasomal degradation by 
assembling K11 chains, thus allowing the transition from metaphase to anaphase 
[72–75]. In 2013, Mevissen et al. showed the ovarian tumor (OTU) DUBs Cezanne’s 
and Cezanne2’s linkage specificity towards K11 chains [76]. In 2014, Bremm and 
co-workers described Cezanne as a new regulator of HIF1 α homeostasis [77], where 
HIF1 α is ubiquitinated with K11 chains. The knockdown of Cezanne increases the 
amount of K11 polyubiquitin chains and decreases the activity of HIF1 α . HIF1 α 
degradation was not disrupted by inhibition of the proteasome suggesting an alter-
native degradation pathway—possible through chaperone-mediated autophagy—to 
HIF1 α [77]. Cezanne can bind and disassemble K11 chains on APC/C substrates 
Figure 2. 
Complex ubiquitin chains. Homotypic ubiquitin chains can be extended by a different type of chain leading 
to a mixed ubiquitin chain. If the ubiquitin chain is modified not at the last ubiquitin moiety, a branched 
ubiquitin chain is created. For mixed ubiquitin/Ubl chains, two attachment points are possible: either as a cap 
structure, modifying the last ubiquitin, or as a branching point on one of the ubiquitins in the middle.
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stabilizing them leading to cell proliferation [78]. Finally, K11 chains were shown 
to replace K48 chains in the transcription factor Met4 activating it [79], so far only 
seen to be ubiquitinated with K48 chains leading to transcription repression [80]. 
Although the exact composition of the newly synthesized K11 chains is still not 
known, the authors suggest that these chains can either be homotypic K11 chains or 
heterotypic K11/K48 chains [79].
K27 chains are still the least studied of all ubiquitin chains. E3 protein ligase 
HACE1 has been shown to assemble K27 chains onto both optineurin and YB-1 [81, 
82], indicating a role in secretion through the multivesicular body (MVB) pathway. 
The ubiquitin ligase RNF168 assembles K27 ubiquitin chains on chromatin linking 
them to the DNA damage response pathway [83]. During pathogen infection, K27 
chain assembly triggers immune response through the recruitment of TBK1 [84, 
85]. The NEDD4 family E3 ligases, Itch and WWP2, promote K27 polyubiquitina-
tion of SHP-1 enhancing the strength of the T-cell receptor (TCR) signal and in turn 
negatively regulating in TH2 cell differentiation [86]. USP19, a deubiquitinating 
enzyme, removes K27 chains from TRIF, thus inhibiting its recruitment by TLR3/
TLR4 and consequently inhibiting TLR3−/TLR4-mediated innate immune response 
[87]. The E3 ligase Hectd3 assembles K27 chains on Malt1 and Stat3 promoting 
differentiation of pathogenic TH17 cells in experimental autoimmune encephalo-
myelitis (EAE), a mouse model for human multiple sclerosis [88].
K29 has been implicated in the Wnt signaling pathway. The E3 ubiquitin ligase, 
EDD, promotes K29 ubiquitination of  β -catenin leading to higher protein levels and 
enhanced activity [89]. E3 ubiquitin ligase SMURF1 promotes K29 ubiquitination 
of axin, thus disrupting its association with LRP5/LRP6 and inhibiting the Wnt sig-
naling pathway [90]. The ubiquitin thioesterase ZRANB1, also known as TRABID, 
preferentially hydrolyzes K29 and K33 chains [4, 55, 57, 91]. Although TRABID/
ZRANB1 was proposed to bind and hydrolyze K63 chains from the APC tumor 
suppressor protein acting as a positive regulator of the Wnt signaling pathway [92], 
no evidence has been shown, linking TRABID and K29 chains in the Wnt signaling 
pathway. More recently, TRABID has been implicated in epigenetic regulation, 
where it regulates Il12 and Il23 genes by TLR. TRABID associates with and stabilizes 
Jmjd2d by hydrolyzing K29 chains regulating histone modifications and expression 
of Il12a, Il12b, and Il23a genes [93].
K33 chains have seen to be implicated in autoimmunity. RING-type E3 ligase 
Cbl-b and HECT-type E3 ligase Itch assemble K33 chains to the TCR- ζ and nega-
tively regulate its phosphorylation and consequently TCR signaling [94]. Later 
in 2014, Lin et al. reported the inhibition of the type I IFN signaling due to the 
interaction of the DUB USP38 and TBK1, after viral infection. USP38 hydrolyzes 
K33 chains from TBK1 promoting K48 polyubiquitination by DTX4/TRIP for its 
degradation through NLRP4 [95]. During infection with uropathogenic E.coli, 
compartmentalized TLR4 signaling is triggered, and TRAF3 is K33 polyubiquiti-
nated leading to the expulsion of intracellular bacteria by the exocyst complex [96]. 
After TGF- β stimulation, USP2a removes K33 polyubiquitin chains from the TGFBR 
promoting the recruitment of R-SMADs and consequently promoting metasta-
sis [97]. A role of K33 chains in trafficking was also suggested. KLHL20, a BTB 
domain-containing adapter protein, recruits Cul-3 assembling K33 chains to Cm7. 
The ubiquitination of Cm7 promotes its recruitment to the trans-Golgi network 
(TGN) [98].
More recently, K33 chains have been implicated in autophagy. E3 ligase RNF166 
binds and assembles K33 chains to the autophagy adaptor p62. This mechanism 
seems to be essential in targeting bacteria to autophagy [99]. SMURF1 induces K29- 
and K33-linked polyubiquitin of UVRAG, triggering a mechanism that promotes 
autophagosome maturation and inhibits HCC growth. TRABID/ZRANB1 forms a 
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complex with UVRAG and cleaves SMURF1-induced K29- and K33-linked polyu-
biquitin chains from UVRAG inhibiting autophagosome flux and leading to poor 
prognosis [100].
M1 chains and their importance in signaling pathways and disease have been 
extensively reviewed [101, 102]. M1 chains are generated by the linear ubiquitin 
chain assembly complex (LUBAC), composed by HOIP, HOIL-1, and SHARPIN 
[103–105]. M1 chains play a crucial role in TNF signaling and immune response 
[104–109]. Formation of complex 1 starts when TNF binds TNFR1, resulting in 
the recruitment of TRADD and RIPK1. After binding to TNFR1, TRADD recruits 
TRAF2 which then recruits cIAP1 or cIAP2, two E3 protein ligases which assemble 
K11, K48, and K63 chains to several components of the complex. LUBAC is then 
recruited by the complex and assembles M1 chains to several components of the 
complex including NEMO, an essential modulator of NF- κ B, RIPK1, TRADD, and 
TNFR1. This process then recruits the TAK1-TAB protein complex and the IKK 
complex (IKK α , IKK β, and NEMO). While the TAK1-TAB complex activates MAPK 
cascades triggering JNK and p38 MAPK leading to the activation of the transcrip-
tion factor AP-1, the IKK complex activates NF- κ B signaling. In the absence of 
LUBAC, complex 2 instead of complex 1 is formed leading to cell death either by 
apoptosis or programmed necrosis.
K48 is the most abundant and well-studied ubiquitin chains and a major signal 
for proteasome degradation [60, 61, 110]. It was initially proposed that signal-
ing through a polyubiquitin chain was mandatory for proteasome degradation 
[111–113]. However, several publications seem to show that monoubiquitination can 
also target proteins for proteasome degradation [114–116].
K63 is the second most abundant ubiquitin chain in cells [60, 61] and it is 
implicated in immune response, DNA repair, endocytosis, and protein trafficking 
(reviewed in [117–119]). K63 chains seem to be essential for the activation of the 
IKK signaling pathway through TRAF6 [120]. TRAF6 also induces K63 ubiquitina-
tion of Akt which is then phosphorylated, activated, and recruited to the membrane 
[121]. RIG-I is regulated by K63 chains where TRIM25 assembles K63 chains to 
RIG-I [122]. K63 ubiquitination of IRAK1 is required for the activation of NF-κB 
signaling [123]. INF- β signaling pathway is activated when STING is ubiquitinated 
with K63 chains assembled by TRIM56 [124]. K63 ubiquitination and protein 
trafficking and DNA damage have been extensively reviewed [119, 125]. Two of the 
most well-studied examples on protein trafficking are the MHC I and EGFR. MHC 
class I molecules are polyubiquitinated with K63 chains leading to degradation 
by an endolysosomal pathway [126]. EGFR is also ubiquitinated and promotes its 
internalization [127, 128]. More recently, it has been shown that K63 chains bind to 
DNA, enhancing the recruitment of repair factors [129].
3.2 Heterotypic chains
Heterotypic chains are composed of several ubiquitin molecules linked together 
through different lysines or N-terminal methionine residues and can be classified as 
mixed chains or branched chains. In mixed chains, each ubiquitin is modified only 
once by another ubiquitin molecule, while in branched chains each ubiquitin can 
be modified by two or more ubiquitin molecules. Chains sharing the same linkage 
types can still have different architectures and thus different structures, resulting 
in a huge number of possible conjugate combinations affecting different signaling 
pathways (reviewed in [130–132]). Due to their architecture, the study of hetero-
typic chains represents a challenge, and their functions in cells are still not clear 
(Figure 2).
K11/K48, K48/K63, and M1/K63 are three of the most studied branched chains.
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K11 and K48 both target proteins for degradation. Branched K11/K48 ubiq-
uitin chains seem to increase this signal leading to a more efficient recognition 
of substrates by the proteasome. The APC/C complex assembles K11 chains to 
substrates, targeting them for protein degradation. During mitosis, the APC/C 
complex conjugates K11/K48 branched chains to the kinase Nek2A leading to a 
more efficient recognition by the proteasome for degradation [133]. The binding 
efficiency of homotypic K11 chains to the proteasome is much lower than that of 
homotypic K48 chains and heterotypic K48/K11 chains, and that both K48 chains 
and K11/K48 chains efficiently target cyclin B1 for proteasome degradation [134]. 
The development of a bispecific antibody to K11/K48 chains allowed the detection 
of APC/C complex assembling K11/K48 chains during mitosis. Under proteotoxic 
stress, leading to the accumulation of newly synthesized and misfolded proteins, 
these linkages seem to accumulate. These chains seem to have a quality control 
role where they prevent protein aggregation by proteasomal degradation. Among 
the effectors of these chains are endogenous p97, BAG6, UBQLN2, p62, UBR5, 
and HUWE1 [135]. More recently, the structure of branched K11/K48-linked 
tri-ubiquitin was solved, showing the presence of a novel binding surface exclusive 
to branched K11/K48-linked polyUb as a result of a unique interface between the 
branched K11 and K48. This interface binds to Rpn1, one of the proteasomal units 
able to recognize polyUb, and increases binding efficiency [136].
Opposed to K48, K63 chains are non-proteolytic chains playing important 
roles in different signaling pathways. The combination of K48 and K63 chains in 
branched chains seems to play an important role in NF- κ B signaling [137]. Induced 
by IL-1 β signaling, HUWE1 cooperates with K63 ubiquitinated TRAF6 to assemble 
K48 chains to the previously assembled K63 chains. The addition of the K48 chains 
does not interfere with the recognition by TAB2 but protects K63 chains from 
deubiquitination by CYLD, enhancing the NF- κ B signaling [137]. Interestingly, 
K63 branched chains seem to target proteins for proteasome degradation. The 
ubiquitin ligase ITCH is involved in apoptosis regulation through the ubiquitination 
of TXNIP [138]. ITCH assembles K63 chains to TXNIP that act as a recruitment 
signal for UBR5 which then assembles K48 branched chains. Because ITCH is a 
tumor-promoting and anti-apoptotic factor and TXNIP is a tumor suppressor and 
pro-apoptotic factor, it is possible that during apoptosis, ITCH accelerates TXNIP 
degradation counteracting its effects [139].
K63/M1 chains, just as M1 and K63 homotypic chains, seem to play a signifi-
cant role in the innate immune response. Upon activation of MyD88, TNFR1/
TRADD, TLR3/TRIF, and NOD1/RIP2 signaling pathways, the formation of K63/
M1 branched chains are induced leading to activation of the IKKs [108, 140]. The 
inflammation-associated protein A20 has both an OTU-type deubiquitinase domain 
and a ZnF4 motif that binds ubiquitin [141]. After phosphorylation, A20 promotes 
disassembly of K63 chains during TNFR1 signaling leading to cell death. However, 
the second step of linear ubiquitination forming branched chains protects TNFR1-
associated proteins from K63 disassembling, maintaining the signaling and leading 
to inflammation [142].
Several other heterotypic chains were found to date. Table 2 gives an overview 
of those chains and their biological significance.
3.3 Ubl/ubiquitin chains
Ubiquitin chains can also be modified by ubiquitin-like modifiers (Figure 2) 
[149–153], and although not much is known about these chains, they increase even 
more the complexity of the ubiquitin code. Ubiquitin chains have been found to be 
modified by SUMO at K6, K11, K27, K48, and K63. Despite the unclear biological 
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role of these modifications, under proteasome inhibition or heat shock conditions, 
K6 and K27 chains seem to accumulate [151]. ISG15 can form mixed chains with 
ubiquitin at K29. These chains have a non-proteolytic function and seem to regulate 
the turnover of ubiquitylated proteins [152]. NEDD8 was found to form branched 
chains with K48 in human cells acting as a chain terminator [153].
4. Detection methods of ubiquitinated target and chains
4.1 Biochemical and genetic methods
Over the years, different biochemical and genetic methods were developed to 
detect ubiquitin, ubiquitin-like modifiers, and ubiquitin chains. Although antibod-
ies were available from early on, problems with specificity led to the use of differ-
ent N-terminally epitope-tagged forms of ubiquitin. Here, antibodies against the 
epitope tag were used for detection. These constructs were elegantly combined with 
molecular biological methods, which replaced single lysine residues in ubiquitin 
with arginine, preventing the formation of ubiquitin chains on these positions. A 
loss of the chain signal was interpreted as the specific modification by ubiquitin 
chain with a specific topology. (For a more comprehensive overview see [154]).
For the enrichment of ubiquitin chains of a specific type, biochemical methods 
and specific antibodies have been developed. While the antibodies were used with 
varying success due to specificity problems, the use of tandem-repeated ubiquitin-
binding entities (TUBE) constructs has gained importance. Here ubiquitin-binding 
domains with specificity for certain chain topologies are multimerized and used as a 
pull-down construct [155].
Ubiquitin chain restriction (UbiCRest) is another alternative to identify polyu-
biquitin chains [76, 156]. In this approach, ovarian tumor family deubiquitinases 
are incubated with substrates and used as restriction enzymes to detect linkage sites 
and determine the relative abundance of Ub chains on substrates [76, 156].
4.2 Mass spectrometry-based methods
Mass spectrometry-based proteomics has been used to detect ubiquitination 
sites for almost 20 years. In 2001, Peng et al. reported that ubiquitinated peptides 
have a 114 Da mass shift due to the diglycine left behind on a lysine sidechain of 
ubiquitin from another ubiquitin, after trypsin digestion [157]. In 2003 the same 
authors, applying their rationale, identified more than 70 ubiquitin-conjugated 
Chain Function Reference
K11/K48 Proteasomal degradation [133–136]
K48/K63 NF- κ B signaling
apoptosis
[137, 139]
K63/M1 Innate immune response [108, 140, 142]
K6/K48 ? [143]
K29/K48 Proteasomal degradation [55, 144–146]
K11/K63 Endocytosis [147]
K29/K33 ? [148]
Table 2. 
Branched ubiquitin chain types and their associated cellular functions.
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proteins and 7 ubiquitination sites (K6, K11, K27, K29, K33, K48, and K63) in 
ubiquitin itself, being 4 of these sites reported for the first time in vivo [158]. In 
2009, Tokunaga et al. reported the identification of linear polyubiquitin in NEMO 
by mass spectrometry, showing that the NF-κB activation pathway is regulated by 
LUBAC through the polyubiquitination of NEMO [106]. Due to the low abundance 
of modified peptides in samples, several enrichment strategies were developed 
to enrich ubiquitinated peptides and improve ubiquitination identification. The 
development of an antibody against diglycine linked to the ε-amino group of lysine 
opened the door to the large-scale identification of ubiquitinated substrate proteins 
[159]. Although the approach was used very successfully by several laboratories 
leading to the identification of close to 20,000 ubiquitination sites [160–162] it has 
some drawbacks. One is that the diglycine remnant left by ubiquitin is not unique, 
and both NEDD8 and ISG15 leave an identical remnant after trypsin digestion. 
Additionally, the antibody does not recognize linear ubiquitination. Recently, 
Akimov et al. developed a new antibody specific to a remnant four-mer peptide of 
the ubiquitin C-terminus after LysC digestion, identifying 60,000 ubiquitination 
sites [163]. Other relative quantification methods like stable isotope labeling by/
with amino acids in cell culture (SILAC), tandem mass tags (TMT), and label-free 
quantification have been successfully applied [160, 164–166]; however, these meth-
ods are using data-dependent measurements, and although they are most suited 
for PTMs discovery, they cannot provide information on absolute quantities and/or 
stoichiometry information.
4.3 Ubiquitin topology analysis
While discovery proteomics based on data-dependent methods (DDA) allows 
the identification of new proteins and can detect the presence of posttranslational 
modifications, the reliable identification and quantification of peptides in several 
samples is hampered by the way how peptides are selected by the mass spectrom-
eter for sequencing. Here, the most intense ion at a very moment is selected, which 
can lead to the selection of different peptides in consecutive mass spectrometric 
analysis runs. Contrary to discovery proteomics methods, targeted proteomics tries 
to identify a given set of peptides in every sample, making this method particularly 
suited for the analysis of ubiquitin topology experiments [167–169].
The most common techniques for targeted proteomics are selected reaction 
monitoring (SRM) and parallel reaction monitoring (PRM). Both methods have 
specific requirements for the mass spectrometer used for the analysis. SRM is 
bound to a triple-quadrupole mass spectrometer, while PRM measurements require 
an Orbitrap mass spectrometer. For both methods, a list of peptides is preselected, 
and the corresponding masses are selected continuously. The selected masses are 
fragmented in a collision cell, and the fragment masses are monitored. In the case 
of the ubiquitin topology analysis, the key peptides for the ubiquitin chains are 
targeted [168]. By comparing this signal with its isotope-labeled version spiked 
into the mix at a known concentration, it is possible to determine the concentration 
of the peptide [170]. For the analysis of ubiquitin chain topology, the analysis is 
focused on unique peptides for each of the ubiquitin chain topologies. By digesting 
a ubiquitin chain with trypsin under denaturing conditions, ubiquitin peptides 
are generated. Ubiquitin carries an arginine residue at position 74. Trypsin cleaves 
after this residue and leaves the double glycine residue on the lysine side chain. 
This creates a branched peptide with an additional mass of 114 Da at the point 
of modification. For the targeted analysis are seven branched peptides—for each 
lysine in ubiquitin one—selected and monitored either by SRM or PRM (reviewed 
in [154, 171]).
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4.4 Detection of branched chains
The detection of heterotypic chains represents a challenge. Specific antibodies can 
only recognize ubiquitin or one chain at a time [172–174]. Mass spectrometry-based 
proteomics methodologies are based on the digestion of proteins with a protease, gen-
erally trypsin, which cuts after lysines or arginines [175]. Branched chains harbor two 
or more lysines that are ubiquitinated. Detection of double-ubiquitinated ubiquitin is 
difficult due to two reasons: first, if branch points are separated by several lysines in 
ubiquitin, the two branch points are separated into two separate peptides, leading to 
a loss of the information of the double modification. Second, if the two branch points 
are on adjacent lysines, the resulting peptide is too long to be measured on a mass 
spectrometer. An alternative is the coupling of antibody-based enrichment with mass 
spectrometric analysis [80, 155, 159]. Limited proteolysis associated with middle-
down proteomics has been used to characterize polyubiquitin chain structures 
[143, 145]. Top-down proteomics associated with ultraviolet photodissociation was 
also applied to determine polyubiquitin chain topology [176]. In 2014, Meyer et al. 
inserted a TEV cleavage site in ubiquitin which after cleavage allowed for the discrim-
ination between branched and unbranched chains [133]. The authors showed that 
APC/C synthesizes branched chains that enhance proteasome degradation. Later in 
2016, Ohtake et al. used a mutagenesis approach to detect K48/K63 branched chains 
[137]. The authors replaced ubiquitin’s arginine 54 by alanine allowing detection of 
these chains by mass spectrometry and showed how K48 branched chains protect the 
deubiquitination of K63. In 2017, Yau et al. developed bispecific antibodies against 
K11/K48 chains, showing their enhanced signal for protein degradation [135]. More 
recently, Swatek et al. showed that the leader protease of foot and mouth disease virus 
cleaves di-ubiquitin between arginine 74 and the C-terminal diglycine, originating 
one truncated ubiquitin (residues 1–74) and a diglycine modified ubiquitin (residues 
1–74) [177]. The authors used the approach coupled to intact MS to identify and 
quantify ubiquitin chains with one, two, or three branches in whole-cell lysates.
5. Conclusion
Over the last decades, the ubiquitin signaling system has been further and 
further probed, and today it is clear that it is one of the most complex posttransla-
tional cellular signaling systems. It is involved in almost all cellular processes, and 
the possibilities in terms of signaling are staggering. Understanding the different 
signals, which are coded in the ubiquitin chains, is one of the biggest challenges of 
the ubiquitin field, and the identification of branched and mixed chains and the 
cross talk with the universe of ubiquitin-like modifiers poses even more challenges. 
The new tools which are becoming available in combination with new mass spec-
trometric analysis tools will open the horizon for even more layers of signaling and 
promise to unravel this hidden chapter of biology.
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